[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters […]
Continue readingTag: Eli Lilly and Co
Wells Fargo CEO talks up reasons to love the stock — plus, what's behind the market drop
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
[ad_1] GLP-1 Supply Tracker from Ro. Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of […]
Continue reading
How digital health companies are capitalizing on the GLP-1 boom
[ad_1] Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at least twice […]
Continue readingEli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters […]
Continue reading
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are […]
Continue reading
A corner of the cancer therapy market is heating up—Here are the names investors need to know
[ad_1] There’s been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by […]
Continue reading
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
[ad_1] A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | Getty Images Think a friend or colleague should be getting this […]
Continue reading
Eli Lilly stock hits new highs after a regulatory win in China. This is a big deal
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key […]
Continue reading
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
[ad_1] The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | Future Publishing | Getty […]
Continue reading